Treatt

Treatt (LSE: TET)

Currency in GBP

Last close As at 22/09/2023

GBP5.07

▲ −11.00 (−2.12%)

Market capitalisation

GBP300m

Overview
Price performance
Financials
Research
Sector insights
Thematics

Treatt provides innovative ingredient solutions from its manufacturing bases in Europe and North America, principally for the flavours and fragrance industries and multinational consumer goods companies, with particular emphasis on the beverage sector.

Treatt has migrated its business from that of a pure supplier to the food and beverage industries to being a valued partner in the development of new ingredients. Citrus, tea, fruit and vegetable flavours, and health and wellness (mainly sugar reduction) are core areas of focus, with the latter undergoing a structural growth trend.

Latest Insights

Consumer |
Update

10.05.23

Treatt — A strong start to the year

Consumer |
Update

17.04.23

Treatt — Strong revenue growth, profit in line

Consumer |
Update

30.01.23

Treatt — Back to steady growth

Consumer |
Update

01.12.22

Treatt — Rebuilding confidence

Visit Website

Sector

Consumer

Equity Analyst

Milo Bussell

Associate Analyst, Consumer and Media

Key Management

Daemmon Reeve

CEO
Ryan Govender

CFO
Tim Jones

Chairman

Balance Sheet

Forecast net debt (£m)

12.6

Forecast gearing ratio (%)

Share Price Performance

Price Performance
%	1M	3M	12M
Actual	(10.0)	(26.1)	(18.8)
Relative	(14.7)	(27.1)	(22.6)
52 week high/low	724.0p/493.0p

Financials

Treatt’s H123 results suggested that the business is back to greater stability and resilience. Momentum is expected to continue into H2, with current sales growth mainly skewed to price as Treatt continues to recover increased costs. Cash management was also strong during H1. Treatt has made substantial investments in both its assets and people over the last few years to support future growth and the investment phase is largely complete. Management remains optimistic despite the dampened macroeconomic environment, as the market for natural and healthy products remains resilient.